financetom
Business
financetom
/
Business
/
BlackRock First-Quarter Results Exceed Expectations; Net Inflows Slide Year Over Year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlackRock First-Quarter Results Exceed Expectations; Net Inflows Slide Year Over Year
Apr 12, 2024 9:37 AM

12:14 PM EDT, 04/12/2024 (MT Newswires) -- BlackRock ( BLK ) on Friday reported first-quarter results that rose year over year and topped Wall Street's estimates, even though the asset manager's net inflows declined.

The company delivered adjusted earnings of $9.81 per share for the March quarter, climbing from $7.93 a year earlier and topping the Capital IQ-polled consensus of $9.39. Revenue rose 11% to $4.73 billion driven in part by higher performance fees and technology services revenue. The Street's view was for $4.71 billion.

The firm generated total net inflows of $57.19 billion, compared with $110.32 billion in the prior-year quarter. The company said the latest quarterly inflows reflect $19 billion of net outflows from cash management, impacted by roughly $14 billion of net redemptions during the last week of March ahead of the Good Friday holiday, Chief Financial Officer Martin Small said during an earnings call, according to a Capital IQ transcript.

"Outflows were driven by clients redeeming balances to have cash on hand during a time when many businesses are open, but the financial markets are closed," according to Small. BlackRock's ( BLK ) shares were down 1.5% in midday trading.

First-quarter long-term net inflows came in at $76.41 billion, "partially offset by seasonal outflows from institutional money market funds," Small told analysts. The company's assets under management advanced 15% to a "record" $10.473 trillion, aided by consistent organic growth and positive market movements, BlackRock ( BLK ) said.

Total investment advisory, administration fees and securities lending revenue rose to $3.78 billion from $3.5 billion a year ago. Technology services sales gained 11% on an annual basis, "reflecting sustained demand" for the company's portfolio management software, Aladdin, Small said on the call. Total expenses increased to $3.04 billion from $2.81 billion.

"We see significant growth potential in infrastructure, technology, retirement and whole portfolio solutions," Chief Executive Laurence Fink said in a statement. "We will continue to stay in front of client needs to deliver long-term growth for our clients, shareholders and employees."

Price: 775.11, Change: -10.86, Percent Change: -1.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
--Nvidia Shares Attempt Rebound Premarket Tuesday After Closing 6.7% Lower Monday
Jun 25, 2024
04:47 AM EDT, 06/25/2024 (MT Newswires) -- Price: 116.57, Change: +0.93, Percent Change: +0.84 ...
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval
Jun 25, 2024
04:41 AM EDT, 06/25/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Tuesday that Roche received European Commission marketing authorization of OCREVUS SC co-formulated with ENHANZE, Halozyme's proprietary recombinant human hyaluronidase enzyme, for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis. OCREVUS SC is a 10-minute injection that maintains the same twice-yearly schedule as the approved...
Novo Nordisk's Wegovy weight-loss drug approved in China
Novo Nordisk's Wegovy weight-loss drug approved in China
Jun 25, 2024
SHANGHAI (Reuters) -Novo Nordisk said on Tuesday its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world's second-largest economy. Novo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. The company did not immediately respond to a Reuters request for comment on...
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
OpenAI to cut access to tools for developers in China and other regions, Chinese state media says
Jun 25, 2024
BEIJING, June 25 (Reuters) - ChatGPT maker OpenAI is planning to block access to technology used to build artificial intelligence products for entities in China and some other countries, a Chinese state-owned newspaper reported on Tuesday. ChatGPT is not available in mainland China but many Chinese startups have been able to access OpenAI's application programming interface (API) platform and use...
Copyright 2023-2026 - www.financetom.com All Rights Reserved